Antibiotics impair response to checkpoint inhibitor therapy

Timing of broad-spectrum antimicrobials 'crucial' to patient response, researchers say

Cancer patients given broad-spectrum antibiotics up to a month before starting immune checkpoint inhibitor therapy have greatly reduced chances of survival, a study suggests.